GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » Research & Development

Sci Pharmtech (TPE:4119) Research & Development : NT$42 Mil (TTM As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Sci Pharmtech Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sci Pharmtech's Research & Development for the three months ended in Mar. 2025 was NT$10 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was NT$42 Mil.

Sci Pharmtech Research & Development Historical Data

The historical data trend for Sci Pharmtech's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sci Pharmtech Research & Development Chart

Sci Pharmtech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.37 30.35 39.65 49.09 42.68

Sci Pharmtech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.60 10.71 10.65 10.72 9.81

Sci Pharmtech Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sci Pharmtech  (TPE:4119) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sci Pharmtech Research & Development Related Terms

Thank you for viewing the detailed overview of Sci Pharmtech's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Sci Pharmtech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » Research & Development
Comparable Companies
ROCO:6785 TPE:4746 ROCO:1799 ROCO:4166 ROCO:6576 TPE:1720 ROCO:6932 ROCO:6620 ROCO:4120 ROCO:4747 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Website
https://www.sci-pharmtech.com.tw
Sci Pharmtech Inc is engaged in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals. Geographically, the primary markets of the company are Italy, Germany, Japan, Taiwan, the United States, China, Switzerland, Spain, and others.

Sci Pharmtech Headlines

No Headlines